The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer.
Francisco TustumiFlávio Roberto TakedaMateus Silva ViyuelaJurandir Batista da Cruz JuniorAntonio Adolfo Guerra Soares BrandãoRubens Antonio Aissar SallumUlysses Ribeiro JuniorIvan CecconelloPublished in: Journal of surgical oncology (2019)
Variables of routine blood count are easily assessable and their changes throughout trimodal therapy for esophageal carcinoma provide important information for cancer patient's prognosis.